09 Dec 2024
Outcome Statements for October 2024 Stakeholder Meetings: Oral Contraceptives and Migraine
Outcome Statements for October 2024 Stakeholder Meetings: Oral Contraceptives and Migraine
06 Dec 2024
Agenda for the December 2024 PBAC Intracycle meeting
Agenda for the December 2024 PBAC Intracycle meeting
04 Dec 2024
Error in the PBS listings for methylphenidate hydrochloride modified release tablet (Concerta, Methylphenidate-TEVA XR, Methylphenidate XR ARX)
Error in the PBS listings for methylphenidate hydrochloride modified release tablet (Concerta, Methylphenidate-TEVA XR, Methylphenidate XR ARX)
04 Dec 2024
2023-24 financial results for cost recovery activities for listing medicines on the PBS and designated vaccines on the NIP
2023-24 financial results for cost recovery activities for listing medicines on the PBS and designated vaccines on the NIP
01 Dec 2024
Pharmaceutical Benefits Scheme (PBS) - Changes to PBS listings for Opdualag® and Vyxeos®
Pharmaceutical Benefits Scheme (PBS) - Changes to PBS listings for Opdualag® and Vyxeos®
01 Dec 2024
PBAC Recommendations for amendments to COVID-19 oral treatment restrictions
PBAC Recommendations for amendments to COVID-19 oral treatment restrictions
01 Dec 2024
Expanded access to dapagliflozin for type 2 diabetes patients with high cardiovascular risk
Expanded access to dapagliflozin for type 2 diabetes patients with high cardiovascular risk
